v3.26.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
shares in Thousands, $ in Thousands
Total
MiX Combination
FC Acquisition
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Common Stock
MiX Combination
Common Stock
FC Acquisition
Additional Paid-In Capital
Additional Paid-In Capital
MiX Combination
Additional Paid-In Capital
FC Acquisition
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non-Controlling Interest *
 [1]
Beginning balance (in shares) at Dec. 31, 2022         37,605                    
Beginning balance at Dec. 31, 2022 $ 68,983     $ 200 $ 376     $ 219,055     $ (140,806) $ 200 $ (1,210) $ (8,510) $ 78
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (17,307)             (11,632)     (5,675)        
Net income attributable to non-controlling interest 35                           35
Foreign currency translation adjustment 583                       594   (11)
Shares issued in connection with Combination 1,347   $ 0         1,347              
Issuance of restricted shares (in shares)         1,247                    
Issuance of restricted shares         $ 13     (13)              
Shares withheld pursuant to vesting of restricted stock (141)                         (141)  
Forfeiture of restricted shares (in shares)         (152)                    
Forfeiture of restricted shares         $ (2)     2              
Exercise of stock options (in shares)         16                    
Exercise of stock options 36             36              
Stock-based compensation 3,908             3,908              
Ending balance (in shares) at Dec. 31, 2023         38,716                    
Ending balance at Dec. 31, 2023 57,644       $ 387     212,703     (146,281)   (616) (8,651) 102
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (19,639)             (11,124)     (8,515)        
Net income attributable to non-controlling interest 11                           11
Foreign currency translation adjustment (377)                       (369)   (8)
Shares issued in connection with Combination     0                        
Shares withheld pursuant to vesting of restricted stock (31)                         (31)  
Forfeiture of restricted shares (in shares)         (7)                    
Stock-based compensation 1,028             1,028              
Ending balance (in shares) at Mar. 31, 2024         38,709                    
Ending balance at Mar. 31, 2024 38,636       $ 387     202,607     (154,796)   (985) (8,682) 105
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (51,012)             (25)     (50,987)        
Net income attributable to non-controlling interest 18                           18
Foreign currency translation adjustment (7,843)                       (7,865)   22
Proceeds from private placement, net of costs to issue common stock (in shares)         20,000                    
Proceeds from private placement, net of costs to issue common stock 66,459       $ 200     66,259              
Acquired through MiX Combination 7,823             7,818             5
Shares issued in connection with Combination (in shares)           70,704 4,286                
Shares issued in connection with Combination   $ 362,005 21,343     $ 707 $ 43   $ 361,298 $ 21,300          
Issuance of restricted shares (in shares)         54                    
Issuance of restricted shares         $ 1     (1)              
Shares issued for transaction bonus (in shares)         174                    
Shares issued for transaction bonus 889       $ 1     888              
Shares withheld pursuant to vesting of restricted stock (2,836)                         (2,836)  
Issue of stock appreciation rights (in shares)         842                    
Exercise of stock options (in shares)         610                    
Exercise of stock options 1,898       $ 4     1,894              
Stock-based compensation $ 9,362             9,362              
Ending balance (in shares) at Mar. 31, 2025 133,316       135,379                    
Ending balance at Mar. 31, 2025 $ 446,742       $ 1,343     671,400     (205,783)   (8,850) (11,518) 150
Increase (Decrease) in Stockholders' Equity                              
Net loss attributable to common stockholders (20,552)                   (20,552)        
Net income attributable to non-controlling interest 608                            
Foreign currency translation adjustment 38,510                       38,510    
Shares issued in connection with Combination     $ 0                        
Issue of stock appreciation rights (in shares)         832                    
Exercise of stock options (in shares)         13                    
Exercise of stock options 39             39              
Stock-based compensation 7,541             7,541              
Dividends declared $ (38)                           (38)
MiX Africa Equity rebalancing   $ 3,364             $ 3,364            
Ending balance (in shares) at Mar. 31, 2026 134,158       136,224                    
Ending balance at Mar. 31, 2026 $ 475,606       $ 1,343     $ 682,344     $ (226,335)   $ 29,660 $ (11,518) $ 112
[1] Excludes redeemable non-controlling interests.